Monday, September 20, 2021

Inspired Advice: How Do You Keep from Feeling Isolated?

 

This article was posted on the OCRA website on May 27, 2021.       \

"When COVID-19 swept across the globe, self-isolation became a new reality for many. But as pandemic-related restrictions have started to lift, those living with ovarian cancer may still find themselves struggling with feelings of isolation. It’s not uncommon to experience these emotions at any stage of a gynecologic cancer, from diagnosis to treatment and beyond. But there are ways to cope. Read on to get advice from others who have found ways to keep from feeling alone."


Thursday, September 16, 2021

Adjusting to Life with Cancer

This article is from the ACS Website.

"A diagnosis of cancer impacts many parts of your life – whether you have just found out you have cancer, are getting treated, or have finished treatment. You likely feel both physical and emotional changes which can impact the way you feel and how you live. These changes may affect daily life, but there are ways to cope." 

Read more...

Monday, September 13, 2021

OCRA-Funded Study Identifies Antibiotic Found to Kill Tumor Cells Containing BRCA Mutations

 

This article was posted on the OCRA website on June 30, 2021.     

"A long-running study from Dana-Farber Cancer Institute, published in Nature Cancer and co-funded by OCRA, has discovered that the antibiotic novobiocin is capable of targeting and killing tumor cells in laboratory cell lines and tumor models with BRCA1 or BRCA2 genetic mutations–and is effective even in tumors that have become resistant to PARP inhibitors."

Read more...

Monday, September 6, 2021

How is Immunotherapy for Ovarian Cancer Changing the Outlook for Patients?


This article was written by a team at Memorial Sloan Kettering Center and reviewed by Dmitriy Zamarin, M.D., Ph.D.

"Immunotherapy for ovarian cancer shows tremendous potential for addressing this devastating disease and several clinical trials testing new treatments are currently underway."

Read more...